Joanna Kopecka

4.9k total citations
92 papers, 3.7k citations indexed

About

Joanna Kopecka is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Joanna Kopecka has authored 92 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 37 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Joanna Kopecka's work include Drug Transport and Resistance Mechanisms (25 papers), Nanoparticle-Based Drug Delivery (16 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Joanna Kopecka is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Nanoparticle-Based Drug Delivery (16 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Joanna Kopecka collaborates with scholars based in Italy, France and Israel. Joanna Kopecka's co-authors include Chiara Riganti, Elena Gazzano, Dario Ghigo, Iris C. Salaroglio, Ivana Campia, Amalia Bosìa, Dimas Carolina Belisario, Elísabeth Pérez-Ruiz, Javier De Las Rivas and Ana Bela Sarmento‐Ribeiro and has published in prestigious journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joanna Kopecka

92 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Kopecka Italy 38 1.9k 1.0k 935 447 431 92 3.7k
Lei Zhong China 32 2.8k 1.4× 871 0.9× 856 0.9× 277 0.6× 269 0.6× 104 5.3k
Ruifang Niu China 38 2.5k 1.3× 969 1.0× 972 1.0× 548 1.2× 413 1.0× 87 3.9k
S. Asha Nair India 34 2.0k 1.1× 891 0.9× 592 0.6× 332 0.7× 299 0.7× 80 3.8k
Hongjuan Zhao United States 37 2.2k 1.2× 795 0.8× 886 0.9× 352 0.8× 392 0.9× 97 4.2k
Carlo Leonetti Italy 41 3.2k 1.7× 1.8k 1.8× 684 0.7× 283 0.6× 360 0.8× 129 5.1k
Francesca Bianchini Italy 38 2.4k 1.2× 1.3k 1.3× 1.3k 1.4× 153 0.3× 734 1.7× 118 4.7k
Lido Calorini Italy 37 2.1k 1.1× 1.3k 1.3× 1.2k 1.3× 147 0.3× 656 1.5× 106 3.9k
Satoshi Kashiwagi United States 27 1.5k 0.8× 602 0.6× 473 0.5× 389 0.9× 524 1.2× 75 4.0k
Borhane Annabi Canada 41 2.2k 1.1× 1.1k 1.1× 1.2k 1.3× 207 0.5× 516 1.2× 151 4.8k
Anant Narayan Bhatt India 23 1.1k 0.6× 612 0.6× 475 0.5× 396 0.9× 374 0.9× 67 2.7k

Countries citing papers authored by Joanna Kopecka

Since Specialization
Citations

This map shows the geographic impact of Joanna Kopecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Kopecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Kopecka more than expected).

Fields of papers citing papers by Joanna Kopecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Kopecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Kopecka. The network helps show where Joanna Kopecka may publish in the future.

Co-authorship network of co-authors of Joanna Kopecka

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Kopecka. A scholar is included among the top collaborators of Joanna Kopecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Kopecka. Joanna Kopecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kopecka, Joanna, Mauro Niso, Rosanna Rizzi, et al.. (2024). First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer. Journal of Medicinal Chemistry. 67(22). 20118–20134. 2 indexed citations
2.
Andreana, Ilaria, Joanna Kopecka, Lorenzo Mino, et al.. (2024). Designing functionalized nanodiamonds with hyaluronic acid–phospholipid conjugates for enhanced cancer cell targeting and fluorescence imaging capabilities. Nanoscale. 16(24). 11610–11622. 9 indexed citations
3.
Godel, Martina, Simona Fontana, Muhlis Akman, et al.. (2024). Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro. Fluids and Barriers of the CNS. 21(1). 89–89. 9 indexed citations
4.
Salaroglio, Iris C., Fabrizio Tabbò, Sofia La Vecchia, et al.. (2023). Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(19). 3958–3973. 17 indexed citations
5.
Panuzzo, Cristina, Alessandro Maglione, Serena Stanga, et al.. (2023). mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International Journal of Molecular Sciences. 24(2). 1234–1234. 6 indexed citations
6.
Kopecka, Joanna, Fabio Arnesano, Nicola Margiotta, et al.. (2023). Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells. Pharmacological Reports. 75(6). 1588–1596. 7 indexed citations
7.
Hattinger, Claudia Maria, Iris C. Salaroglio, Martina Godel, et al.. (2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences. 24(1). 799–799. 8 indexed citations
8.
Campani, Virginia, Iris C. Salaroglio, Valeria Nele, et al.. (2022). Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors. Pharmaceutics. 14(2). 292–292. 9 indexed citations
9.
Petrillo, Sara, Joanna Kopecka, Tullio Genova, et al.. (2021). Endothelial Heme Dynamics Drive Cancer Cell Metabolism by Shaping the Tumor Microenvironment. Biomedicines. 9(11). 1557–1557. 8 indexed citations
10.
Niso, Mauro, et al.. (2021). Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models. Cellular Oncology. 44(6). 1307–1323. 15 indexed citations
11.
Roux, Cecilia, et al.. (2021). IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants. 10(3). 422–422. 5 indexed citations
12.
Riganti, Chiara, et al.. (2020). MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor. International Journal of Molecular Sciences. 21(9). 3333–3333. 20 indexed citations
13.
Stefanachi, Angela, Chiara Riganti, Joanna Kopecka, et al.. (2020). Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R). European Journal of Medicinal Chemistry. 188. 112037–112037. 16 indexed citations
14.
Gazzano, Elena, Ilaria Buondonno, Alessandro Marengo, et al.. (2019). Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts. Cancer Letters. 456. 29–39. 54 indexed citations
15.
Salaroglio, Iris C., Prashant Mujumdar, Laura Annovazzi, et al.. (2018). Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein–Mediated Resistance to Temozolomide in Glioblastoma. Molecular Cancer Therapeutics. 17(12). 2598–2609. 36 indexed citations
16.
Salaroglio, Iris C., Elisa Panada, Enrico Moiso, et al.. (2017). PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Molecular Cancer. 16(1). 91–91. 157 indexed citations
17.
Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations
18.
Buondonno, Ilaria, Elena Gazzano, Sae Rin Jean, et al.. (2016). Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Molecular Cancer Therapeutics. 15(11). 2640–2652. 83 indexed citations
19.
Gazzano, Elena, Konstantin Chegaev, Barbara Rolando, et al.. (2014). Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells. Molecular Pharmaceutics. 11(9). 3068–3079. 23 indexed citations
20.
Dobiášová, M, et al.. (1978). [Lecithin: cholesterol acyltransferase determination (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 117(44-45). 1394–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Zhong Breakdown of academic impact, for papers by Ruifang Niu Breakdown of academic impact, for papers by S. Asha Nair Breakdown of academic impact, for papers by Hongjuan Zhao Breakdown of academic impact, for papers by Carlo Leonetti Breakdown of academic impact, for papers by Francesca Bianchini Breakdown of academic impact, for papers by Lido Calorini Breakdown of academic impact, for papers by Satoshi Kashiwagi Breakdown of academic impact, for papers by Borhane Annabi Breakdown of academic impact, for papers by Anant Narayan Bhatt
Rankless by CCL
2026